Previously treated non-squamous non-small cell lung cancer
Conditions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1)Histologically or cytologically proven non-squamous non-small cell lung cancer (without large cell neuroendocrine carcinoma) 2)Non-squamous non-small cell cancer patients with stage IIIB,stage IV or recurrent disease after surgery,who have previously treated 2-5 chemoterapy regimens 3)Measurable lesions not required 4)More than 4 weeks after the last chemoterapy (More than 2 weeks after the last UFT,TS-1,gefitinib and erlotinib) 5)If the patient underwent radiotherapy, there should be the following interval between the radiotherapy and the registration i)Radiotherapy including pulmonary field ->3 months ii)Radiotherapy other than thoracic radiation ->1 month 6)20 years or older 7)ECOG PS 0-2 8)Adequate organ function 9)Life expectancy more than 3 months 10)Written informed consent
Exclusion criteria
Exclusion criteria: 1)Interstitial pneumonia or pulmonary fibrosis detectable on CT scan 2)History of drug induced interstitial pneumonia 3)History of severe drug allergy 4)History of active infection or other serious disease condition (GI bleeding,etc.) 5)History of poorly controlled pleural effusion,pericardial effusion and ascites 6)History of severe heart disease(uncontrollable arrythmia,uncontrollable angina pectoris,herat failure,etc.) 7)Uncontrollable diabetes mellitus 8)History of symptomatic brain metastases 9)Hystory of active double cancer 10)History of active psychological disease 11)History of pregnancy or lactation 12)Patients whose participation in the trial is judged to be inappropriate by the attending doctor
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Progression free survival | — |
Secondary
| Measure | Time frame |
|---|---|
| Overall survival Response rate Disease control rate Safety | — |
Countries
Japan
Contacts
Hyogo Cancer Center Department of Thoracic Oncology